Fibrillex

Introduction

<orphan drug status in the U.S. and in Europe>

Indications

• AA amyloidosis Phase II/III clinical trials in 2003)

Mechanism of action

? Neurochem Inc (Canada)

More general terms

• miscellaneous pharmacologic agent